The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea - PubMed (original) (raw)
Review
The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea
Brian W Hurley et al. Arch Intern Med. 2002.
Abstract
Pseudomembranous (entero)colitis is primarily caused by Clostridium difficile infection. The most common predisposing factor is prior use of antibiotics, including vancomycin and metronidazole, which themselves are therapy for C difficile colitis. Other risk factors have also been described. The presence of C difficile in the gastrointestinal tract leads to a spectrum of manifestations from the asymptomatic carrier state to fulminant colitis. Successful treatment of C difficile colitis requires prompt treatment with appropriate antibiotics, withdrawal of the suspected predisposing antibiotics, and, in rare cases, total colectomy. Preventive measures of adequate infection control and judicious use of antibiotics are necessary means in attempting to control the spread of C difficile infection. Attempts at making an effective human vaccine are currently under way.
Similar articles
- Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
Nelson R. Nelson R. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD004610. doi: 10.1002/14651858.CD004610.pub3. Cochrane Database Syst Rev. 2007. PMID: 17636768 Updated. Review. - Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
Nelson RL, Kelsey P, Leeman H, Meardon N, Patel H, Paul K, Rees R, Taylor B, Wood E, Malakun R. Nelson RL, et al. Cochrane Database Syst Rev. 2011 Sep 7;(9):CD004610. doi: 10.1002/14651858.CD004610.pub4. Cochrane Database Syst Rev. 2011. PMID: 21901692 Updated. Review. - Clostridium difficile infection in older adults: a review and update on its management.
Kee VR. Kee VR. Am J Geriatr Pharmacother. 2012 Feb;10(1):14-24. doi: 10.1016/j.amjopharm.2011.12.004. Epub 2012 Jan 20. Am J Geriatr Pharmacother. 2012. PMID: 22260856 Review. - Clinical manifestations, treatment and control of infections caused by Clostridium difficile.
Bouza E, Muñoz P, Alonso R. Bouza E, et al. Clin Microbiol Infect. 2005 Jul;11 Suppl 4:57-64. doi: 10.1111/j.1469-0691.2005.01165.x. Clin Microbiol Infect. 2005. PMID: 15997485 Review. - Clostridium difficile-associated diarrhea and colitis: clinical manifestations, diagnosis, and treatment.
Cleary RK. Cleary RK. Dis Colon Rectum. 1998 Nov;41(11):1435-49. doi: 10.1007/BF02237064. Dis Colon Rectum. 1998. PMID: 9823813 Review.
Cited by
- A Case of Clostridioides difficile Infection of a Pregnant Woman Treated with Colectomy.
Tekin S, İrkören P, Sucu S, Kartal K. Tekin S, et al. Infect Dis Clin Microbiol. 2022 Dec 21;4(4):293-298. doi: 10.36519/idcm.2022.156. eCollection 2022 Dec. Infect Dis Clin Microbiol. 2022. PMID: 38633715 Free PMC article. - A novel macrolide-Del-1 axis to regenerate bone in old age.
Sirisereephap K, Tamura H, Lim JH, Surboyo MDC, Isono T, Hiyoshi T, Rosenkranz AL, Sato-Yamada Y, Domon H, Ikeda A, Hirose T, Sunazuka T, Yoshiba N, Okada H, Terao Y, Maeda T, Tabeta K, Chavakis T, Hajishengallis G, Maekawa T. Sirisereephap K, et al. iScience. 2024 Jan 4;27(2):108798. doi: 10.1016/j.isci.2024.108798. eCollection 2024 Feb 16. iScience. 2024. PMID: 38261928 Free PMC article. - Probiotics for the prevention of antibiotic-associated diarrhoea: a systematic review and meta-analysis.
Goodman C, Keating G, Georgousopoulou E, Hespe C, Levett K. Goodman C, et al. BMJ Open. 2021 Aug 12;11(8):e043054. doi: 10.1136/bmjopen-2020-043054. BMJ Open. 2021. PMID: 34385227 Free PMC article. - Immunosuppression and Clostridioides (Clostridium) difficile Infection Risk in Metabolic and Bariatric Surgery Patients.
Morales-Marroquin E, Xie L, Uppuluri M, Almandoz JP, Cruz-Muñoz N, Messiah SE. Morales-Marroquin E, et al. J Am Coll Surg. 2021 Aug;233(2):223-231. doi: 10.1016/j.jamcollsurg.2021.04.028. Epub 2021 May 17. J Am Coll Surg. 2021. PMID: 34015452 Free PMC article. - Changes in the Association Between Diagnostic Testing Method, Polymerase Chain Reaction Ribotype, and Clinical Outcomes From Clostridioides difficile Infection: One Institution's Experience.
Menon A, Perry DA, Motyka J, Weiner S, Standke A, Penkevich A, Keidan M, Young VB, Rao K. Menon A, et al. Clin Infect Dis. 2021 Nov 2;73(9):e2883-e2889. doi: 10.1093/cid/ciaa1395. Clin Infect Dis. 2021. PMID: 32930705 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical